A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in The Oncology Institute, Inc. W stock. As of the latest transaction made, Citadel Advisors LLC holds 17,808 shares of TOIIW stock, worth $178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,808
Previous 17,908 0.56%
Holding current value
$178
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.01 - $0.03 $1 - $3
-100 Reduced 0.56%
17,808 $0
Q2 2024

Aug 14, 2024

BUY
$0.02 - $0.23 $90 - $1,042
4,534 Added 33.9%
17,908 $0
Q1 2024

May 15, 2024

SELL
$0.12 - $0.3 $1,059 - $2,649
-8,831 Reduced 39.77%
13,374 $2,000
Q4 2023

Feb 14, 2024

SELL
$0.07 - $0.26 $743 - $2,762
-10,624 Reduced 32.36%
22,205 $4,000
Q3 2023

Nov 14, 2023

BUY
$0.02 - $0.21 $96 - $1,011
4,819 Added 17.2%
32,829 $2,000
Q2 2023

Aug 14, 2023

BUY
$0.03 - $0.08 $321 - $856
10,703 Added 61.84%
28,010 $0
Q1 2023

May 15, 2023

BUY
$0.07 - $0.2 $1,211 - $3,461
17,307 New
17,307 $1,000

Others Institutions Holding TOIIW

About THE ONCOLOGY INSTITUTE, INC. W


  • Ticker TOIIW
More about TOIIW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.